Literature DB >> 12762970

Heart disease in diabetic patients.

Mihaela C Blendea1, Samy I McFarlane, Esma R Isenovic, Gregory Gick, James R Sowers.   

Abstract

Both type 1 and type 2 diabetic patients have an increased incidence of ischemic heart disease and congestive heart failure. Cardiovascular disease accounts for up to 80% of the excess mortality in patients with type 2 diabetes. The burden of cardiovascular disease is especially pronounced in diabetic women. Factors that underlie diabetic heart disease include multiple vessel coronary artery disease, long-standing hypertension, metabolic derangements such as hyperglycemia and dyslipidemia, microvascular disease, and autonomic neuropathy. There is also increased sudden death associated with diabetes, which is due, in part, to the underlying autonomic neuropathy. This article reviews diabetic cardiac disease, with an emphasis on type 2 diabetes.

Entities:  

Mesh:

Year:  2003        PMID: 12762970     DOI: 10.1007/s11892-003-0068-z

Source DB:  PubMed          Journal:  Curr Diab Rep        ISSN: 1534-4827            Impact factor:   4.810


  73 in total

Review 1.  Insulin resistance and cardiovascular disease.

Authors:  S I McFarlane; M Banerji; J R Sowers
Journal:  J Clin Endocrinol Metab       Date:  2001-02       Impact factor: 5.958

2.  The effect of adjusting for baseline risk factors and post revascularisation coronary disease on comparisons between coronary angioplasty and bypass surgery.

Authors:  A S Kurbaan; T J Bowker; C D Ilsley; R A Foale; U Sigwart; A F Rickards
Journal:  Int J Cardiol       Date:  2001-02       Impact factor: 4.164

3.  Influence of cardiac autonomic neuropathy on heart rate dependence of ventricular repolarization in diabetic patients.

Authors:  Paul E Valensi; Nicolas B Johnson; Pierre Maison-Blanche; Fabrice Extramania; Gilbert Motte; Philippe Coumel
Journal:  Diabetes Care       Date:  2002-05       Impact factor: 19.112

Review 4.  Diabetes and cardiovascular disease.

Authors:  J R Sowers; M A Lester
Journal:  Diabetes Care       Date:  1999-04       Impact factor: 19.112

Review 5.  Silent coronary artery disease in diabetes--a feature of autonomic neuropathy or accelerated atherosclerosis?

Authors:  K E Airaksinen
Journal:  Diabetologia       Date:  2001-02       Impact factor: 10.122

6.  Reduced cardiovascular morbidity and mortality in hypertensive diabetic patients on first-line therapy with an ACE inhibitor compared with a diuretic/beta-blocker-based treatment regimen: a subanalysis of the Captopril Prevention Project.

Authors:  L Niskanen; T Hedner; L Hansson; J Lanke; A Niklason
Journal:  Diabetes Care       Date:  2001-12       Impact factor: 19.112

7.  Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators.

Authors: 
Journal:  Lancet       Date:  2000-01-22       Impact factor: 79.321

8.  A prospective study of maturity-onset diabetes mellitus and risk of coronary heart disease and stroke in women.

Authors:  J E Manson; G A Colditz; M J Stampfer; W C Willett; A S Krolewski; B Rosner; R A Arky; F E Speizer; C H Hennekens
Journal:  Arch Intern Med       Date:  1991-06

Review 9.  The role of PCI and CABG in the management of coronary artery disease in patients with diabetes.

Authors:  Robert L Frye; Malcolm R Bell; Hartzell V Schaff; Richard Holubkov; Katherine M Detre
Journal:  Curr Diab Rep       Date:  2002-02       Impact factor: 4.810

Review 10.  Oxidative stress and diabetic cardiomyopathy: a brief review.

Authors:  L Cai; Y J Kang
Journal:  Cardiovasc Toxicol       Date:  2001       Impact factor: 3.231

View more
  22 in total

Review 1.  Exercise training: can it improve cardiovascular health in patients with type 2 diabetes?

Authors:  K J Stewart
Journal:  Br J Sports Med       Date:  2004-06       Impact factor: 13.800

2.  Mitigating the cardiovascular risk of anemia in patients with type 2 diabetes and CKD: Does darbepoetin help? The TREAT Trial.

Authors:  Christi Hayes; Anis Alam; Julie Black-Peart; Samy I McFarlane
Journal:  Curr Diab Rep       Date:  2010-04       Impact factor: 4.810

3.  Gain of function of cardiac ryanodine receptor in a rat model of type 1 diabetes.

Authors:  Chengju Tian; Chun Hong Shao; Caronda J Moore; Shelby Kutty; Timothy Walseth; Cyrus DeSouza; Keshore R Bidasee
Journal:  Cardiovasc Res       Date:  2011-03-18       Impact factor: 10.787

4.  Impact of diabetes in patients with pulmonary hypertension.

Authors:  Abraham D Abernethy; Kathryn Stackhouse; Stephen Hart; Ganesh Devendra; Thomas M Bashore; Raed Dweik; Richard A Krasuski
Journal:  Pulm Circ       Date:  2015-03       Impact factor: 3.017

Review 5.  Anemia and cardiovascular disease in diabetic nephropathy.

Authors:  Samy I McFarlane; Moro O Salifu; John Makaryus; James R Sowers
Journal:  Curr Diab Rep       Date:  2006-06       Impact factor: 4.810

6.  Thrombin stimulates VSMC proliferation through an EGFR-dependent pathway: involvement of MMP-2.

Authors:  Katarina Smiljanic; Milan Obradovic; Aleksandra Jovanovic; Jelena Djordjevic; Branislava Dobutovic; Danimir Jevremovic; Pierre Marche; Esma R Isenovic
Journal:  Mol Cell Biochem       Date:  2014-07-22       Impact factor: 3.396

7.  Symptoms across the continuum of acute coronary syndromes: differences between women and men.

Authors:  Holli A DeVon; Catherine J Ryan; Amy L Ochs; Moshe Shapiro
Journal:  Am J Crit Care       Date:  2008-01       Impact factor: 2.228

Review 8.  Should we treat prehypertension in diabetes? What are the cons?

Authors:  Ehud Grossman
Journal:  Diabetes Care       Date:  2009-11       Impact factor: 19.112

9.  Early recognition of heart failure in patients with diabetes type 2 in primary care. A prospective diagnostic efficiency study. (UHFO-DM2).

Authors:  Leandra J M Boonman-de Winter; Frans H Rutten; Maarten J Cramer; Anho H Liem; Marcel J Landman; Henk F van Stel; G Ardine de Wit; Guy E H M Rutten; Paulien A W van Hessen; Arno W Hoes
Journal:  BMC Public Health       Date:  2009-12-21       Impact factor: 3.295

10.  Increased prevalence of ventricular fibrillation in patients with type 2 diabetes mellitus.

Authors:  Mohammad-Reza Movahed; Mehrtash Hashemzadeh; Mazen Jamal
Journal:  Heart Vessels       Date:  2007-07-20       Impact factor: 2.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.